For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

Pulmonologists expecting to see an increase in individuals with respiratory issues due to the ongoing fires in Los Angeles County have added time for patients to their clinic schedules, Cedars-Sinai ...

Pulmocide recently completed a Phase 2 safety and tolerability clinical trial (OPERA-S study) in lung transplant patients receiving inhaled opelconazole monotherapy as prophylaxis against pulmonary ...

Kolkata: The mercury fluctuation is causing various ailments, including persistent cough, runny nose, throat congestion, and ...

When a cold strikes, you want fast, effective relief. And while grabbing the first over-the-counter cold medication seems ...

Research led by Brock University has found a possible cure for lung diseases typically found in older adults, such as pulmonary fibrosis. The findings are published in the journal Aging Cell.

Exceeds the Upper End of Guidance Range for Full-Year 2024 with Unaudited Global Revenues of Approximately $363.7 Million-- --2025 Global ARIKAYCE Revenues Expected to be Between $405 Million ...

A two-drug combination extended OS compared with standard first-line osimertinib for certain patients with advanced lung ...

Lung cancer remains one of the deadliest cancers globally. Non-small cell lung cancer (NSCLC), which accounts for 85% of all lung cancer cases, is particularly challenging to treat due to difficulties ...

Researchers from POSTECH and Kyungpook National University have developed a novel inhalable therapeutic delivery system for ...